- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 25th, 2005
Lumera Corp. announced it has acquired the exclusive rights to Helix Biopharma's Heterodimer Protein Technology (HPT). The technology moves Lumera closer to launching a unique product set aimed to capitalize on the multi-billion dollar proteomic array market.
The combination of the Helix HPT technology and Lumera's proprietary nanosurface modification chemistry will, for the first time, allow researchers to consistently take existing DNA arrays to produce protein arrays that accurately mimic the native living cell environment of the body.
|Related News Press|
Nanometrics Announces Upcoming Investor Events July 20th, 2016
Scientists change properties of zeolites to improve hemodialysis July 29th, 2016
Pixel-array quantum cascade detector paves the way for portable thermal imaging devices: Research team from TU-Wien Center for Micro- and Nanostructures have developed a new 'cooler' sensing instrument thereby increasing energy-efficiency and enhancing mobility for diagnostic tes July 28th, 2016
A new type of quantum bits July 29th, 2016